Fact
601fd235bce6d1cb481c628428dcc2a998c5080820c6d4f6a6c075ed2b8e13dd| Field | Value |
|---|---|
| Fact | 601fd235bce6d1cb481c628428dcc2a998c5080820c6d4f6a6c075ed2b8e13dd |
| Field | site-address |
| Value | Former Novartis Pharmaceuticals (South) |
| Entity | SA390 |
| Earliest entry date | 2019-12-31 |
| Latest entry date | 2024-12-30 |
| Latest resource | a59262189b9577e667657a2b760cdaa3a5b8a8eef2898e552c6f593993454831 |
| Entry Date | Resource |
|---|---|
| 2019-12-31 | 3c5c9ae14196edda0251438ef70cca1537e82ae2193f2931f2822a0b7942f339 |
| 2024-12-30 | a59262189b9577e667657a2b760cdaa3a5b8a8eef2898e552c6f593993454831 |
| 2019-12-31 | de89a45c889de7b6d6a430bba52d7a0988e5452558a89aaf20a69d891b05b31b |